MTAP and fibrosarcoma: This concords with a recently published study that found a catalytically inactive version of MTAP, which was introduced into HT1080 fibrosarcoma cells, to be fully capable of reversing various tumor phenotypes such as soft agar colony formation and increased migration and metalloproteinase production [34].